MR [Mindray Medical International] 20-F/A: (Original Filing)
[]
[U.S.GAAP International Financial Reporting Standards issued STYLE="font-family:Times New Roman" SIZE="2">by the International Accounting Standards Board Other TABLE OFNTENTS Page EXPLANATORY NOTE 1 2 3 EX-101 INSTANCE DOCUMENT EX-101HEMA DOCUMENT EX-101LCULATION LINKBASE DOCUMENT EX-101 DEFINITION LINKBASE DOCUMENT EX-101 LABELS LINKBASE DOCUMENT EX-101 PRESENTATION LINKBASE DOCUMENT EXPLANATORY NOTE No other changes have been made to the Form]
[U.S.GAAP International Financial Reporting Standards issued STYLE="font-family:Times New Roman" SIZE="2">by the International Accounting Standards Board Other TABLE OFNTENTS Page EXPLANATORY NOTE 1 2 3 EX-101 INSTANCE DOCUMENT EX-101HEMA DOCUMENT EX-101LCULATION LINKBASE DOCUMENT EX-101 DEFINITION LINKBASE DOCUMENT EX-101 LABELS LINKBASE DOCUMENT EX-101 PRESENTATION LINKBASE DOCUMENT EXPLANATORY NOTE No other changes have been made to the Form]
[U.S.GAAP International Financial Reporting Standards issued by the International Accounting Standards Board Other TABLE OFNTENTS Page EXPLANATORY NOTE 1 2 3 EX-101 INSTANCE DOCUMENT EX-101HEMA DOCUMENT EX-101LCULATION LINKBASE DOCUMENT EX-101 DEFINITION LINKBASE DOCUMENT EX-101 LABELS LINKBASE DOCUMENT EX-101 PRESENTATION LINKBASE DOCUMENT EXPLANATORY NOTE No other changes have been made to the Form 20-F. This Amendment]
[] [HEYER MEDICAL AG Unit 2006, Tower D, Yuanyang International Center 62 DongSiHuan Middle Road, Chaoyang District Beijing 100025 T: 010-85185165 sales@heyer.cn Email: www.heyermedical.de Authorization Agreement HEYER Medical, AG DEHAIER Medical Technology Co., Ltd , So hereby is authorized. This authorization is valid from January 1, 2011 to December 31, 2012. HEYER Medical, Ag Gao, Wei Sales and Marketing Manager Mi,] [Labor Contract Beijing Dehaier Medical Technology Company Limited Party A: Yanying Qi Party B: September 30, 2011 LABOR CONTRACT Beijing Dehaier Medical Technology Co. Ltd. (hereinafter referred to as “Party A”) and Name of Employee: Yanying Qi Identification Card No.: (hereinafter referred to as “Party B”) hereby execute this Contract in accordance with the applicable provisions of “The Labor Law] [I, Ping Chen, certify that: (1) I have reviewed this Form of ; (2) Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the] [Certification of Principal Financial Officer I, Aileen Qi, certify that: (1) I have reviewed this Form 10-Q of Dehaier Medical Systems Limited; (2) Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such] [18 U.S.C. SECTION 1350, SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 (2) The information contained in the this period report fairly presents, in all material respects, the financial condition and results of operations of Dehaier Medical Systems Limited. Ping Chen] [18 U.S.C. SECTION 1350, SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 (2) The information contained in the this period report fairly presents, in all material respects, the financial condition and results of operations of Dehaier Medical Systems Limited. Aileen Qi Chief Financial Officer (Principal Financial Officer)]
[] [HEYER MEDICAL AG Unit 2006, Tower D, Yuanyang International Center 62 DongSiHuan Middle Road, Chaoyang District Beijing 100025 T: 010-85185165 sales@heyer.cn Email: www.heyermedical.de Authorization Agreement HEYER Medical, AG DEHAIER Medical Technology Co., Ltd , So hereby is authorized. This authorization is valid from January 1, 2011 to December 31, 2012. HEYER Medical, Ag Gao, Wei Sales and Marketing Manager Mi,] [Labor Contract Beijing Dehaier Medical Technology Company Limited Party A: Yanying Qi Party B: September 30, 2011 LABOR CONTRACT Beijing Dehaier Medical Technology Co. Ltd. (hereinafter referred to as “Party A”) and Name of Employee: Yanying Qi Identification Card No.: (hereinafter referred to as “Party B”) hereby execute this Contract in accordance with the applicable provisions of “The Labor Law] [I, Ping Chen, certify that: (1) I have reviewed this Form of ; (2) Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the] [Certification of Principal Financial Officer I, Aileen Qi, certify that: (1) I have reviewed this Form 10-Q of Dehaier Medical Systems Limited; (2) Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such] [18 U.S.C. SECTION 1350, SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 (2) The information contained in the this period report fairly presents, in all material respects, the financial condition and results of operations of Dehaier Medical Systems Limited. Ping Chen] [18 U.S.C. SECTION 1350, SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 (2) The information contained in the this period report fairly presents, in all material respects, the financial condition and results of operations of Dehaier Medical Systems Limited. Aileen Qi Chief Financial Officer (Principal Financial Officer)]
[Mindray Announces First Quarter 2012 Financial Results Shenzhen, China May 7, 2012 Mindray Medical International Limited (NYSE: MR), a leading developer, manufacturer and marketer of medical devices worldwide, announced today its selected unaudited financial results for the first quarter ended March 31, 2012. Highlights for First Quarter 2012 Net revenues were $219.0 million, an increase of 21.1%]
[Mindray Announces First Quarter 2012 Financial Results Shenzhen, China May 7, 2012 Mindray Medical International Limited (NYSE: MR), a leading developer, manufacturer and marketer of medical devices worldwide, announced today its selected unaudited financial results for the first quarter ended March 31, 2012. Highlights for First Quarter 2012 Net revenues were $219.0 million, an increase of 21.1%]
[Mindray Announces First Quarter 2012 Financial Results STYLE="font-family:Times New Roman" SIZE="2"> Shenzhen, China May7, 2012 Mindray Medical International Limited (NYSE: MR), a leading developer, manufacturer and marketer of medical devices worldwide, announced today its selected unaudited financial results for the first quarter ended March31, 2012. Highlights for First Quarter 2012 Net revenues were $219.0 million,]